Shanghai Fosun Pharmaceutical Group Co Ltd (600196) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others.

Total Assets Chart for Shanghai Fosun Pharmaceutical Group Co Ltd

Shanghai Fosun Pharmaceutical Group Co Ltd (600196) total assets for FY2025 were CNY 120.5B, a 2.6% change from FY2024. Shanghai Fosun Pharmaceutical Group Co Ltd's total assets grew from CNY 106.7M in 1995 to CNY 120.5B in 2025 (112805.2% over 30 years). Total assets compound annual growth rate: 5-year CAGR of 7.6%, 10-year CAGR of 12.2%, 20-year CAGR of 16.5%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (CNY)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
¥61.77B
Implied Share Price
¥29.16
Enterprise Value
¥82.32B
Revenue (TTM)
¥42.59B
EBITDA
¥5.90B
Profit Margin
7.96%
Trailing P/E
18.07
Forward P/E
17.76
Price/Book (MRQ)
1.27
Price/Sales (TTM)
1.45
EV/EBITDA
8.35
EV/Revenue
1.93
Dividend Yield
1.69%
Book Value
¥18.46
Free Cash Flow (FY2025)
¥1.56B
Free Cash Flow Yield
2.52%

Snapshot as of 23rd September 2026 — not point-in-time controlled, may lag the live market by a few days.